2021
DOI: 10.1016/j.carbpol.2020.117103
|View full text |Cite
|
Sign up to set email alerts
|

Drug delivery systems based on CD44-targeted glycosaminoglycans for cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
46
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 94 publications
(48 citation statements)
references
References 176 publications
2
46
0
Order By: Relevance
“…Several HA based nanomaterials are used in hyperthermia (an increase in the temperature of the cancer cells at about 42–46°C): NIR-loaded nanoparticles, gold nanoparticles, functionalized graphene, oxide nanoparticles, Prussian Blue nanoparticles, and other particles (related to magnetic hyperthermia treatment). In addition, HA based nanoparticles were used in photodynamic therapy, immunotherapy, and sonodynamic therapy [ 31 , 32 , 33 , 34 , 35 , 36 , 37 ].…”
Section: Applications Of Hyaluronic Acidmentioning
confidence: 99%
“…Several HA based nanomaterials are used in hyperthermia (an increase in the temperature of the cancer cells at about 42–46°C): NIR-loaded nanoparticles, gold nanoparticles, functionalized graphene, oxide nanoparticles, Prussian Blue nanoparticles, and other particles (related to magnetic hyperthermia treatment). In addition, HA based nanoparticles were used in photodynamic therapy, immunotherapy, and sonodynamic therapy [ 31 , 32 , 33 , 34 , 35 , 36 , 37 ].…”
Section: Applications Of Hyaluronic Acidmentioning
confidence: 99%
“…In cases where the upregulation of the HAS2 expression was prevented, the DNA damage increased and the survival rate of the irradiated cells decreased. Since HA provides support for cancer cells, the bond between CD44 and HA comprises one of the subjects of ongoing research in the field of anticancer therapy 108 . Leukemic cells also produce high amounts of HA.…”
Section: Proposed Mechanisms Of the Ha Regulation Of Photoagingmentioning
confidence: 99%
“…Osteosarcoma is a primary bone cancer characterised by cancer cells that produce calcified osteoid extracellular matrix and inducing lung metastases with a high frequency [4]. Despite recent advances in treating osteosarcoma with a combination of chemotherapy and surgery, the 5-year survival rate remains low, and the prognosis for patients is poor [5]. The cellular and molecular mechanisms underlying the progression of osteosarcoma, including the rate of cancer cell proliferation, the formation of metastatic lesions and the development of drug resistance, remain unclear.…”
Section: Introductionmentioning
confidence: 99%